title: Platelet amyloid precursor protein forms in AD: a peripheral diagnostic tool and a pharmacological target.
abstract: Alzheimer Disease (AD) is characterized by the progressive deposition of beta-amyloid in the parenchyma and cerebral microvasculature. The beta-amyloid peptide derives from the metabolism of a larger precursor, Amyloid Precursor Protein (APP). This protein is present in central nervous system, but it is also expressed in peripheral tissues such as circulating cells. An alteration of the APP forms pattern in platelets has been recently reported in AD patients when compared to platelets both of control subjects or non AD patients (NADD). The accuracy of the assay to identify AD is high and decreased levels are found throughout the course of AD with a significant association with severity of symptoms. Moreover, a recent study has demonstrated that AD patients on donepezil (5 mg daily) for 4 weeks displayed two-fold increase in their APPr baseline levels up to normal range. Thus, platelet APP ratio (APPr) holds the potential to be a clinical marker, which might be of helpful and adjunctive value in the diagnosis of AD and in tracking the course of illness, also in the early stages when pharmacological treatment has the greatest potential of being effective.
authors.affiliation: Dipartimento Scienze Mediche e Chirurgiche, Clinica Neurologica-Università degli Studi di Brescia, Piazza Ospedale 1, 25125, Brescia, Italy. padovani@bshosp.osp.unibs.it
authors.forename: A
authors.initials: A
authors.lastname: Padovani
authors.forename: B
authors.initials: B
authors.lastname: Borroni
authors.forename: F
authors.initials: F
authors.lastname: Colciaghi
authors.forename: L
authors.initials: L
authors.lastname: Pastorino
authors.forename: S
authors.initials: S
authors.lastname: Archetti
authors.forename: E
authors.initials: E
authors.lastname: Cottini
authors.forename: L
authors.initials: L
authors.lastname: Caimi
authors.forename: F
authors.initials: F
authors.lastname: Cattabeni
authors.forename: M
authors.initials: M
authors.lastname: Di Luca
mesh_terms: D000544:Alzheimer Disease / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy; D016564:Amyloid beta-Protein Precursor / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D001792:Blood Platelets / Q000378:metabolism*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D000077265:Donepezil; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use
chemical_list: D016564:Amyloid beta-Protein Precursor; D015415:Biomarkers; D002800:Cholinesterase Inhibitors; D007189:Indans; D010880:Piperidines; D000077265:Donepezil